Related references
Note: Only part of the references are listed.Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling
Nils P. Nickel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Therapeutic potential of human elafin
Lee Shaw et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival
Tero-Pekka Alastalo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension
SHE Zaidi et al.
CIRCULATION (2002)
Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor
AW Barolet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
KN Cowan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
